Key Events This Week
15 Jun: Golden Cross formation signals potential bullish breakout
16 Jun: Technical momentum shifts to bullish amid mixed market returns
19 Jun: Week closes at Rs.797.10, up 3.65% for the week
Jul 31, 03:30 PM
BSE+NSE Vol: 96.25 k

Astec LifeSciences Ltd., a Mumbai-based manufacturer of agrochemicals and pharmaceutical intermediates, reported a consolidated net loss of ₹18.72 crores for Q1 FY27 ended June 2026, marking a 43.34% deterioration year-on-year compared to a loss of ₹33.04 crores in Q1 FY26. The company's revenue declined 8.26% YoY to ₹83.56 crores, reflecting persistent challenges in the agrochemical sector. The stock closed at ₹657.00 on July 31, 2026, down 27.45% over the past year, significantly underperforming both the Sensex and its sectoral peers.
Read full news article
Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news articleAstec Lifesciences Ltd is scheduled to declare its results on July 31, 2026....
Read full news article
Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators reveal a nuanced picture that investors must carefully analyse amid broader market trends.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend. Despite a recent day decline of 2.10%, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from Bollinger Bands and on-balance volume. This article analyses the evolving technical landscape and what it means for investors navigating this volatile stock.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s price action and technical indicators reveal a cautiously optimistic outlook tempered by underlying weaknesses.
Read full news articleAstec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the Quarter ended June 30 2026
Please find enclosed compliance certificate.
Please find enclosed copies of newspaper publication.
No Upcoming Board Meetings
Astec Lifesciences Ltd has declared 15% dividend, ex-date: 21 Jul 23
No Splits history available
No Bonus history available
Astec Lifesciences Ltd has announced 1:7 rights issue, ex-date: 04 Jul 25